vitae
General Information
| Full Name | Dongmin (Eugene) Bang |
| Languages | English, Korean |
| Summary | PharmD, PhD in Bioinfomatics, with interest in AI for medicine and drug discovery |
Education
-
2025 PhD in Bioinformatics (August, 2025)
Seoul National University, Seoul, Republic of Korea - Advisor: Prof. Sun Kim
- Dissertation: Modeling Multi-Scale Biomedical Interactions via Transfer Learning and Knowledge Integration for Precision Medicine
-
2021 PharmD
Chung-Ang University, Seoul, Republic of Korea - College of Pharmacy
-
2021 BSE(c)
Hanyang University, Seoul, Republic of Korea - Architectural Engineering
Experience
-
2022 - Present Senior Research Scientist
Institute for AI Drug Discovery, AIGENDRUG Co., Ltd. - Developing AI algorithms for drug discovery, from drug response to candidate filtering
- Construction of workflows for drug discovery pipelines
- (KR) Patents
- APPARATUS AND METHOD FOR MEASURING DRUG-INDUCED HEPATOTOXICITY (Filing Date: 23 Nov 2023, Registration date: 16 Jul 2024)
- APPARATUS AND METHOD FOR DRUG REPURPOSING (Filing Date: 23 Nov 2023, Registration date: 3 Dec 2024)
Honors and Awards
-
2024 - Research Grant: Advanced Medical Researcher Training Support Program (Funded by Seoul National University)
- Best Paper Award, BIOINFO 2024, Gyeongju, Korea
-
2023 - Best Paper Award, BIOINFO 2023, Yeosu, Korea
-
2022 - Best Paper Award in Artificial Intelligence (First among 391), Korea Computer Congress (KCC) 2022, Jeju, Korea
Academic Interests
-
AI for Medicine and Personalized Therapy
- Perturbation and cell state transition
- Multi-omics integration and Foundational Modeling
- Systems Pharmacology and Knowledge Graph Learning
-
AI for Drug Discovery
- Molecular representation learning and ADMET prediction
- Intelligent Knowledge Integration